国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2015年
5期
890-891
,共2页
卢文胜%王晓冰%韩冬%郝翠霞%高宁洲%杨绍辉%吕建华
盧文勝%王曉冰%韓鼕%郝翠霞%高寧洲%楊紹輝%呂建華
로문성%왕효빙%한동%학취하%고저주%양소휘%려건화
青光眼引流阀%先天性青光眼%眼压失控
青光眼引流閥%先天性青光眼%眼壓失控
청광안인류벌%선천성청광안%안압실공
Ahmed glaucoma valve implantation%primary congenital glaucoma%uncontrolled intraocular pressure
目的：探讨Ahmed青光眼引流阀植入治疗先天性青光眼术后眼压失控的疗效与安全性。<br> 方法：回顾分析了2011-01/2014-12因先天性青光眼术后眼压失控患者22例22眼,行青光眼引流阀植入术。主要检查指标包括手术前后眼压、角膜直径以及并发症。<br> 结果：术前平均年龄3.74±2.24岁,距上次手术平均2.59±1.78a,术前平均眼压35.22±6.36mmHg,平均水平角膜直径12.79±0.75mm。所有眼术中使用丝裂霉素C 0.3~0.5mg/mL 3~5min,青光眼引流阀植入颞上或鼻上方巩膜赤道部。术后1wk 眼压11.4±4.45mmHg,术后12mo随访眼压16.73±7.23mmHg。以眼压<21mmHg为成功标准,术后12 mo 16眼(73%)眼压控制。术后6例发生浅前房,均自行恢复。所有患者未发生引流阀排斥及眼内炎、角膜失代偿等严重并发症。<br> 结论：Ahmed青光眼引流阀植入治疗先天性青光眼术后眼压失控,是一种安全、有效的方法。
目的：探討Ahmed青光眼引流閥植入治療先天性青光眼術後眼壓失控的療效與安全性。<br> 方法：迴顧分析瞭2011-01/2014-12因先天性青光眼術後眼壓失控患者22例22眼,行青光眼引流閥植入術。主要檢查指標包括手術前後眼壓、角膜直徑以及併髮癥。<br> 結果：術前平均年齡3.74±2.24歲,距上次手術平均2.59±1.78a,術前平均眼壓35.22±6.36mmHg,平均水平角膜直徑12.79±0.75mm。所有眼術中使用絲裂黴素C 0.3~0.5mg/mL 3~5min,青光眼引流閥植入顳上或鼻上方鞏膜赤道部。術後1wk 眼壓11.4±4.45mmHg,術後12mo隨訪眼壓16.73±7.23mmHg。以眼壓<21mmHg為成功標準,術後12 mo 16眼(73%)眼壓控製。術後6例髮生淺前房,均自行恢複。所有患者未髮生引流閥排斥及眼內炎、角膜失代償等嚴重併髮癥。<br> 結論：Ahmed青光眼引流閥植入治療先天性青光眼術後眼壓失控,是一種安全、有效的方法。
목적：탐토Ahmed청광안인류벌식입치료선천성청광안술후안압실공적료효여안전성。<br> 방법：회고분석료2011-01/2014-12인선천성청광안술후안압실공환자22례22안,행청광안인류벌식입술。주요검사지표포괄수술전후안압、각막직경이급병발증。<br> 결과：술전평균년령3.74±2.24세,거상차수술평균2.59±1.78a,술전평균안압35.22±6.36mmHg,평균수평각막직경12.79±0.75mm。소유안술중사용사렬매소C 0.3~0.5mg/mL 3~5min,청광안인류벌식입섭상혹비상방공막적도부。술후1wk 안압11.4±4.45mmHg,술후12mo수방안압16.73±7.23mmHg。이안압<21mmHg위성공표준,술후12 mo 16안(73%)안압공제。술후6례발생천전방,균자행회복。소유환자미발생인류벌배척급안내염、각막실대상등엄중병발증。<br> 결론：Ahmed청광안인류벌식입치료선천성청광안술후안압실공,시일충안전、유효적방법。
?AlM: To investigate the outcome and safety of Ahmed glaucoma valve implantation treatment in uncontrolled primary congenital glaucoma ( PCG) . <br> ? METHODS: Twenty - two eyes in 22 children with uncontrolled PCG were reviewed retrospectively and underwent Ahmed glaucoma valve implantation treatment from January 2011 to December 2014. Main checking index included intraocular pressure ( lOP ) before and after operation, corneal diameter and complications. <br> ?RESULTS: Preoperative mean age was 3. 74±2. 24y, and 2. 59 ± 1. 78y apart from the last operation. Postoperative average lOP was 35. 22 ± 6. 36mmHg. Average corneal diameter was 12. 79 ± 0. 75mm. Mitomycin C ( 0. 3 - 0. 5mg/mL ) was used in all operations for 3-5min. Glaucoma valves were implanted in the temporal or nose above the equator sclera. Postoperative lOP was 11. 4±4. 45mmHg at 1wk, and 16. 73± 7. 23mmHg after 12mo. As lOP< 21mmHg for success criteria, lOP of 16 eyes ( 73%) were controlled after 12mo. Preoperative 6 cases had shallow anterior chamber, recovered spontaneously. No serious complication was recorded, such as rejection of glaucoma valve, endoophthalmitis and corneal decompensation. <br> ?CONCLUSlON:Ahmed glaucoma valve implantation in uncontrolled PCG is a safe and viable treatment.
